Pre-analytical error in a hematology laboratory: an avoidable cause of compromised quality in reporting

The impact of biosafety enhancement on stat laboratory quality metrics: Lessons from the COVID-19 pandemic

OBJECTIVE

It is unclear if implementation of biosafety action plans in response to the COVID-19 pandemic has affected laboratory quality metrics.

METHODS

This retrospective study used quality data, including turnaround time (TAT) and number/type of unacceptable specimens from a stat laboratory supporting an outpatient medical clinic serving predominantly elderly cancer patients. Four months of data from the height of the COVID-19 pandemic (March-June 2020) were compared to the same months in 2019.

RESULTS

March-May 2020 test volumes were decreased compared to 2019. June 2020 test volume was slightly increased compared to 2019. TATs in 2020 were similar/ slightly improved compared to the same months in 2019, due to shortened collect to receive and receive to verify TATs. The number and types of unacceptable specimens were similar in 2020 and 2019.

CONCLUSIONS

Despite the challenges to the system caused by the pandemic, laboratory quality metrics were maintained.